Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Jul 11, 2016 $7.00 $7.00 $7.00 $7.00 50
Jul 08, 2016 $7.00 $7.00 $7.00 $7.00 100
Jul 07, 2016 $6.25 $6.25 $6.25 $6.25 0
Jul 06, 2016 $6.05 $6.40 $6.05 $6.25 2 200
Jul 05, 2016 $6.15 $6.15 $6.15 $6.15 0
Jul 01, 2016 $6.00 $6.15 $6.00 $6.15 610
Jun 30, 2016 $7.15 $7.15 $6.10 $6.10 800
Jun 29, 2016 $7.50 $7.50 $7.50 $7.50 290
Jun 28, 2016 $7.51 $7.51 $7.51 $7.51 65
Jun 27, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 24, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 23, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 22, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 21, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 20, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 17, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 16, 2016 $7.51 $7.51 $7.51 $7.51 0
Jun 15, 2016 $7.51 $7.51 $7.51 $7.51 250
Jun 14, 2016 $7.50 $7.50 $7.50 $7.50 450
Jun 13, 2016 $7.75 $7.75 $7.75 $7.75 100
Jun 10, 2016 $7.56 $7.56 $7.56 $7.56 0
Jun 09, 2016 $7.56 $7.56 $7.56 $7.56 125
Jun 08, 2016 $7.75 $7.75 $7.50 $7.50 2 192
Jun 07, 2016 $8.00 $8.00 $8.00 $8.00 0
Jun 06, 2016 $8.00 $8.00 $8.00 $8.00 0
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT